KMD Bioscience has dedicated years to antibody development research. Monoclonal antibodies are produced by monoclonal hybridoma cells formed through the fusion of activated B lymphocytes with myeloma cells.Our team comprises experienced antibody development technicians who have accumulated extensive expertise and specialized skills. Combined with well-equipped antibody production facilities, we provide customized monoclonal antibody services for various species.
Mice are one of the common model organisms in biology and medicine. Murine monoclonal antibodies are widely utilized, offering advantages such as high specificity and the capability for rapid, large-scale, and continuous production.KMD Bioscience offers clients two distinct approaches for murine monoclonal antibody development:Preparation of recombinant monoclonal antibodies using Phage Display Technology and preparation of hybridoma cell lines using Cell Fusion Technology.Clients can provide antigens including small molecules, peptides, modified peptides, fusion proteins, and modified proteins for monoclonal antibody development.
Based on our established Antibody Platform system, we provide comprehensive end-to-end services spanning upstream and downstream processes, including Antigen Design, Synthesis and Modification, Aanimal Immunization, Phage Display Library Construction and Screening, as well as Downstream Antibody Modification and Application Validation. Simultaneously, we offer antigen preparation services covering DNA Synthesis, Plasmid Construction, Protein Expression, Protein Purification, Peptide Synthesis and Modification, Small Molecule Structural Analysis, and Conjugation to Carrier Proteins. Furthermore, our antibody team possesses extensive experience in developing IVD-grade antibodies and antigens, with deep expertise in antibody selection and characterization; to meet diverse client requirements, we provide personalized customization and screening solutions.
0
